Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Quick take on safety: bonds vs cash in retirement, highlighting scenarios where each preserves capital and meets withdrawal needs.
24,731 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
IBM’s profit warning sharpens focus on the Dow’s direction, while technology stocks push Nasdaq higher. Here’s what t...
Looking for breakout growth stocks hold that can power a decade of gains? This guide highlights three durable picks—N...
As miners shift capital from BTC holdings to AI compute, the landscape for there bitcoin mining stocks changes. This ...
Snowflake stock down hard has sparked headlines and worries about growth. But the core platform—cross‑cloud data ware...
With oil prices near a year high, IEO’s $0.55 quarterly dividend is set to be tested by producer payouts and market s...
Oil-driven optimism gave broad indices and airlines a lift, but patience and discipline remain essential. Here’s how ...
Rocket Lab unveiled an approximately $8 billion plan to acquire Iridium, aiming to become a full-stack space operator...
Netflix stock has fallen from its peak, heightening focus on engagement metrics. This guide breaks down what to watch...
Southwest Gas missed Q4 earnings by three cents but reaffirmed its 14% annual growth target through 2030, tying the m...
Crypto swings may lift Coinbase, but the real upside comes from non crypto revenue streams. This guide explains why t...
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...